Pipeline

Mononuclear Therapeutics Limited (MonoTx™) umbilical cord blood mononuclear cell are being developed to treat neurological conditions, including spinal cord injury, stroke, and age-related macular degeneration.

LEARN MORE

Culture Supplements

MonoTx™ cord blood plasma products, superior growth media for cell lines and primary cell cultures.

LEARN MORE

Cord Blood Banking

Donate cord blood. Help save life. Cure hematopoietic diseases including leukemia, lymphoma and other diseases.

 

LEARN MORE

About Mononuclear Therapeutics

Mononuclear Therapeutics Limited (MonoTx™) is dedicated to cord blood mononuclear cell therapy for spinal cord injury, stroke, age-related macular degeneration.

MonoTx™ collects, processes and banks umbilical cord blood for both related and unrelated treatment. Our cord blood bank is AABB accredited and FDA registered.

LEARN MORE

NEWS AND EVENTS

Mononuclear Therapeutics Passed AABB Assessment

Mononuclear Therapeutics Ltd (MonoTx™) in Hong Kong has passed regular assessment of American Association of [...]

Read More
META-PARADE: MonoTx 聯乘 Keith Lam & Dimension Plus 的「Mononuclear Vitality」

新媒體藝術家Keith Lam及其所屬的創作團體 Dimension Plus 受我們的夥伴公司 Mononuclear Therapeutics(MonoTx)的單核細胞療法啟發

Read More
08/01/2020 Press Release

Mononuclear Therapeutics in Hong Kong Science Park attains AABB Accreditation for Hong Kong’s First Mononuclear [...]

Read More